305 related articles for article (PubMed ID: 31324216)
1. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
Richards DM; Marschall V; Billian-Frey K; Heinonen K; Merz C; Redondo Müller M; Sefrin JP; Schröder M; Sykora J; Fricke H; Hill O; Gieffers C; Thiemann M
J Immunother Cancer; 2019 Jul; 7(1):191. PubMed ID: 31324216
[TBL] [Abstract][Full Text] [Related]
2. A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity.
Thiemann M; Richards DM; Heinonen K; Kluge M; Marschall V; Merz C; Redondo Müller M; Schnyder T; Sefrin JP; Sykora J; Fricke H; Gieffers C; Hill O
Front Oncol; 2018; 8():387. PubMed ID: 30298117
[TBL] [Abstract][Full Text] [Related]
3. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
[TBL] [Abstract][Full Text] [Related]
4. The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells.
Merz C; Sykora J; Marschall V; Richards DM; Heinonen K; Redondo Müller M; Thiemann M; Schnyder T; Fricke H; Hill O; Gieffers C
J Immunother; 2018; 41(9):385-398. PubMed ID: 30273198
[TBL] [Abstract][Full Text] [Related]
5. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
[TBL] [Abstract][Full Text] [Related]
6. Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation.
Zhao M; Fu L; Chai Y; Sun M; Li Y; Wang S; Qi J; Zeng B; Kang L; Gao GF; Tan S
Cell Rep; 2021 Sep; 36(12):109734. PubMed ID: 34551288
[TBL] [Abstract][Full Text] [Related]
7. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.
Baltz KM; Krusch M; Bringmann A; Brossart P; Mayer F; Kloss M; Baessler T; Kumbier I; Peterfi A; Kupka S; Kroeber S; Menzel D; Radsak MP; Rammensee HG; Salih HR
FASEB J; 2007 Aug; 21(10):2442-54. PubMed ID: 17360848
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.
Lacal PM; Petrillo MG; Ruffini F; Muzi A; Bianchini R; Ronchetti S; Migliorati G; Riccardi C; Graziani G; Nocentini G
J Pharmacol Exp Ther; 2013 Oct; 347(1):164-72. PubMed ID: 23892569
[TBL] [Abstract][Full Text] [Related]
10. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells.
Yu KY; Kim HS; Song SY; Min SS; Jeong JJ; Youn BS
Biochem Biophys Res Commun; 2003 Oct; 310(2):433-8. PubMed ID: 14521928
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
Nocentini G; Ronchetti S; Petrillo MG; Riccardi C
Br J Pharmacol; 2012 Apr; 165(7):2089-99. PubMed ID: 22029729
[TBL] [Abstract][Full Text] [Related]
12. Identification of glucocorticoid-induced TNF receptor-related protein ligand on keratinocytes: ligation by GITR induces keratinocyte chemokine production and augments T-cell proliferation.
Byrne AM; Goleva E; Leung DY
J Invest Dermatol; 2009 Dec; 129(12):2784-94. PubMed ID: 19536139
[TBL] [Abstract][Full Text] [Related]
13. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
[TBL] [Abstract][Full Text] [Related]
14. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells.
Igarashi H; Cao Y; Iwai H; Piao J; Kamimura Y; Hashiguchi M; Amagasa T; Azuma M
Biochem Biophys Res Commun; 2008 May; 369(4):1134-8. PubMed ID: 18346459
[TBL] [Abstract][Full Text] [Related]
15. Biological role of GITR/GITRL in attributes and immune responses of macrophage.
Fu Z; Wang S; Li J; Zhang Y; Li H; Li G; Wan X; Zhang Y
J Leukoc Biol; 2020 Feb; 107(2):309-321. PubMed ID: 31833599
[TBL] [Abstract][Full Text] [Related]
16. Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions.
Wang F; Chau B; West SM; Kimberlin CR; Cao F; Schwarz F; Aguilar B; Han M; Morishige W; Bee C; Dollinger G; Rajpal A; Strop P
Nat Commun; 2021 Mar; 12(1):1378. PubMed ID: 33654081
[TBL] [Abstract][Full Text] [Related]
17. GITR/GITRL: more than an effector T cell co-stimulatory system.
Nocentini G; Ronchetti S; Cuzzocrea S; Riccardi C
Eur J Immunol; 2007 May; 37(5):1165-9. PubMed ID: 17407102
[TBL] [Abstract][Full Text] [Related]
18. GITR Blockade Facilitates Treg Mediated Allograft Survival.
Sonawane SB; Kim JI; Lee MK; Lee SH; Duff PE; Moore DJ; Lian MM; Deng S; Choi Y; Yeh H; Caton AJ; Markmann JF
Transplantation; 2009 Nov; 88(10):1169-77. PubMed ID: 19935370
[TBL] [Abstract][Full Text] [Related]
19. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells.
Rakké YS; Campos Carrascosa L; van Beek AA; de Ruiter V; van Gemerden RS; Doukas M; Doornebosch PG; Vermaas M; Ter Borg S; van der Harst E; Coene PPLO; Kliffen M; Grünhagen DJ; Verhoef C; IJzermans JNM; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2023; 15(1):77-97. PubMed ID: 36155259
[TBL] [Abstract][Full Text] [Related]
20. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
